Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. 

CEO
Paul Hudson
CEOPaul Hudson
Employees
84,587
Employees84,587
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1994
Founded1994
Employees
84,587
Employees84,587

SNY Key Statistics

Market cap
116.95B
Market cap116.95B
Price-Earnings ratio
12.05
Price-Earnings ratio12.05
Dividend yield
3.30%
Dividend yield3.30%
Average volume
2.34M
Average volume2.34M
High today
$48.64
High today$48.64
Low today
$48.27
Low today$48.27
Open price
$48.37
Open price$48.37
Volume
1.03M
Volume1.03M
52 Week high
$60.12
52 Week high$60.12
52 Week low
$44.62
52 Week low$44.62

SNY News

TipRanks 9h
Sanofi to Buy Dynavax in $2.2 Billion Push Into Adult Vaccines

Claim 70% Off TipRanks This Holiday Season Sanofi ( (SNY) ) has issued an announcement. On December 24, 2025, Sanofi announced an agreement to acquire Dynavax...

TipRanks 20h
Sanofi Hit by FDA Rebuff on Tolebrutinib MS Filing but Sees No Change to 2025 Outlook

Claim 70% Off TipRanks This Holiday Season The latest update is out from Sanofi ( (SNY) ). On December 24, 2025, Sanofi announced that the US Food and Drug Ad...

Nasdaq 4d
Company News for Dec 26, 2025

Shares of NVIDIA Corp. ( NVDA ) fell 0.3% following news that the company is planning to acquire assets from Groq, a designer of high-performance AI accelerator...

Company News for Dec 26, 2025

More SNY News

Simply Wall St 5d
Novavax Is Up 6.3% After Activist Sale Push and Sanofi-Focused Royalty Pivot - What's Changed

In recent months, Novavax has been shifting from direct commercial vaccine sales toward a royalty- and milestone-focused partnership model with Sanofi, while co...

Novavax Is Up 6.3% After Activist Sale Push and Sanofi-Focused Royalty Pivot - What's Changed
The Motley Fool 5d
Why Dynavax Stock Soared Today

A healthcare titan wants to buy the biotech's vaccines. Shares of Dynavax Technologies (DVAX +38.19%) popped on Wednesday after the vaccine maker struck a deal...

Why Dynavax Stock Soared Today
TipRanks 6d
Dynavax downgraded to Market Perform from Outperform at William Blair

William Blair downgraded Dynavax (DVAX) to Market Perform from Outperform after Sanofi (SNY) announced it will acquire the company for $15.50 per share. The ana...

TipRanks 6d
Morning Movers: Intel slipping ahead of holiday shortened-session

Stock index futures are little changed ahead of the holiday shortened session after the benchmark S&P 500 set a record on Tuesday. U.S. stock markets are due to...

MarketWatch 6d
Dynavax soars on deal news and other early market movers

Here are some of the stocks making notable moves in Wednesday's premarket action: Dynavax Technologies stock is up 37% after the vaccine maker agreed to be acq...

Dynavax soars on deal news and other early market movers
Seeking Alpha 6d
Sanofi multiple sclerosis therapy rejected by the FDA

Sanofi (SNY) announced on Wednesday that the U.S. FDA issued a complete response letter regarding its marketing application for tolebrutinib, rejecting the drug...

Sanofi multiple sclerosis therapy rejected by the FDA
TipRanks 6d
Dynavax jumps 37% to $15.31 after buyout offer from Sanofi

06:34 EST Dynavax (DVAX) jumps 37% to $15.31 after buyout offer from Sanofi (SNY) Published first on TheFly – the ultimate source for real-time, market-moving...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.